RelatedLinks

December 21st

December 9th

  • Competitor - Ixempra - Pfizer - against breast cancer tumors resistant or refractory to anthracyclines , taxanes, and capecitabine: IXEMPRA is indicated in combination with capecitabine for the treatment of patients with metastatic or locally advanced breast cancer resistant to treatment with an anthracycline and a taxane, or whose cancer is taxane resistant and for whom further anthracycline therapy is contraindicate d. Anthracycline resistance is defined as progression while on therapy or within 6 months in the adjuvant setting or 3 months in the metastatic setting. Taxane resistance is defined as progression while on therapy or within 12 months in the adjuvant setting or 4 months in the metastatic setting.

December 1st

October 9th

    Video Buzz > Anthracyclines

    Format: AVI | MPEG | Real | Quicktime | Window Media

    No Matching Video

    No video for Anthracyclines is available at this time.

    Related Anthracyclines News

    Anthracyclines Podcasts

    Do you prefer to listen to your anthracyclines gossip? Check out Podzy Podcast Directory > Anthracyclines.

    Anthracyclines Products

    Looking for anthracyclines related products, then look no further. Try our new Anthracyclines Shop.


    Powered by Odin Assemble